Vancouver, Wash.-based biotech company AbSci raised an additional $65 million to help grow its synthetic biology platform. The company’s “Protein… Read More
While telemedicine was making inroads into healthcare before COVID-19 struck, the pandemic has unleashed its potential, according to a panel… Read More
Demand is through the roof for Seattle telemedicine startup 98point6. The company, which helps facilitate virtual primary care appointments, has… Read More
Zoom+Care, the Portland, Ore.-based on-demand health care provider, is expanding beyond its roots in the Pacific Northwest, announcing plans to… Read More
Seattle biotech company Phase Genomics announced Wednesday that it received two National Institutes of Health (NIH) grants totaling $3.9 million.… Read More
Seattle-based biotech startup Immusoft raised another $4.5 million and landed a $467,000 NIH grant to help further development of its drugs… Read More
An international research team led by University of Washington scientists has identified two kinds of “ultrapotent human antibodies” that could… Read More
Seattle biotech startup Silverback Therapeutics continues to raise capital to support development of its therapies for cancer, fibrosis, and other conditions.… Read More
